The study, carried out at the U.O.C. Infectious and Tropical Diseases of the Hospital of Padua, aims to compare the clinical outcome of SARS-CoV2 infection (in terms of hospitalization for COVID-19, duration of hospitalization for COVID-19 and death from COVID-19) with or without early treatment with monoclonal antibodies.
Lo studio, effettuato presso l’U.O.C. Malattie Infettive e Tropicali dell’Azienda Ospedaliera di Padova, si pone come obiettivo quello di confrontare l’outcome clinico dell’infezione da SARS-CoV2 (in termini di ospedalizzazione per COVID-19, durata dell'ospedalizzazione per COVID-19 e decesso per COVID-19) con o senza trattamento precoce con anticorpi monoclonali.
Outcome clinico dell'infezione da SARS-CoV2 con o senza trattamento precoce con monoclonali
BERTOLINI, MARTA
2021/2022
Abstract
The study, carried out at the U.O.C. Infectious and Tropical Diseases of the Hospital of Padua, aims to compare the clinical outcome of SARS-CoV2 infection (in terms of hospitalization for COVID-19, duration of hospitalization for COVID-19 and death from COVID-19) with or without early treatment with monoclonal antibodies.File | Dimensione | Formato | |
---|---|---|---|
Bertolini_Marta.pdf
accesso aperto
Dimensione
2.48 MB
Formato
Adobe PDF
|
2.48 MB | Adobe PDF | Visualizza/Apri |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/40977